Siddeeq Hoosen, Irene Mackraj, Nadine Rapiti. The Success of Treatment Free Remission in Chronic Myeloid Leukaemia in Clinical Practice: A Single-Centre Retrospective Experience from South Africa.Advances in hematology. 2023, 2023: 2004135
Collince Odiwuor Ogolla, Benson Nyanchongi, Rodgers Norman Demba. Association between Blood Group and Change in Coagulation Factors in Plasma Preparations for Transfusion Purpose at Kisii Teaching and Referral Hospital.Advances in hematology. 2023, 2023: 3749773
Takamitsu Sakamoto, Hiroyuki Mizuta, Naohisa Niiro, Teruyoshi Amagai. Retrospective Study to Reduce Blood Transfusion Waste in Remote Island Healthcare Settings.Advances in hematology. 2023, 2023: 5549655
Zahra Malakoutikhah, Farzaneh Ashrafi, Ali Derakhshandeh. Prognostic Factors and Outcome of Patients with Adult Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen: A Retrospective Study.Advances in hematology. 2023, 2023: 5593635
Abdirasak Sharif Ali Mude, Abd Elhadi Mohamed Agena Musa. Exploring Hematological Parameters and Their Prognostic Value in Adult COVID-19 Patients: Insights from Mogadishu, Somalia.Advances in hematology. 2023, 2023: 8862457
Tania Ahuja, Veronica Raco, Sharonlin Bhardwaj, David Green. To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice.Advances in hematology. 2023, 2023: 9511499
Maroun Bou Zerdan, Jason Valent, Maria Julia Diacovo, Karl Theil, Chakra P Chaulagain. Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).Advances in hematology. 2022, 2022: 1182384
Shinya Ohata, Kei Takenaka, Daisuke Sugiyama, Takeshi Sugimoto. Bone Marrow Infiltration Is a Distinctive Risk Factor for Rituximab Infusion-Related Reactions in CD20-Positive B-Cell Non-Hodgkin Lymphoma.Advances in hematology. 2022, 2022: 3688727
Regina Elorm Amoaning, Ernestina Siaw Amoako, Grace Arezie Kyiire, Dennis Dela Owusu, Happy Bruce, David Larbi Simpong, Patrick Adu. Anaemia Prevalence More Than Doubles in an Academic Year in a Cohort of Tertiary Students: A Repeated-Measure Study in Cape Coast, Ghana.Advances in hematology. 2022, 2022: 4005208
Januario E Castro, Paula A Lengerke-Diaz, Juliana Velez Lujan, Michael Y Choi, Eider F Moreno-Cortes, Jose V Forero, Juan Esteban Garcia-Robledo, Chaja Jacobs, Colin McCarthy, Alaina Heinen, Carlos I Amaya-Chanaga, Thomas J Kipps. Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.Advances in hematology. 2022, 2022: 4450824
Mario Petrini, Gianluca Gaidano, Andrea Mengarelli, Ugo Consoli, Armando Santoro, Anna Maria Liberati, Marco Ladetto, Vincenzo Fraticelli, Attilio Guarini, Donato Mannina, Paola Ferrando, Paolo Corradini, Pellegrino Musto, Caterina Stelitano, Dario Marino, Andrea Camera, Marco Murineddu, Roberta Battistini, Giuseppe Caparrotti, Mauro Turrini, Luca Arcaini, Simone Santini, Manuela Cerqueti, Andres J M Ferreri, Nicola Cantore, Alessandro Inzoli, Giovanni Cardinale, Benedetto Ronci, Giorgio La Nasa. Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study.Advances in hematology. 2022, 2022: 5581772
Wesley V Cain, Anne M Sill, Vinod Solipuram, John J Weiss, Carole B Miller, Peter F Jelsma. Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration.Advances in hematology. 2022, 2022: 7992927
Chayanit Jumniensuk, Alexander Nobori, Thomas Lee, T Niroshi Senaratne, Dinesh Rao, Sheeja Pullarkat. Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms.Advances in hematology. 2022, 2022: 8091746